文献速递血管炎

意大利人群中的高安动脉炎与大血管型巨细胞动脉炎:单中心184例队列的综合分析

Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases.
PubMed 文献 · Semin Arthritis Rheum · 2023-02-08

该回顾性单中心研究比较了1996至2016年间诊断的59例高安动脉炎(TAK)与127例大血管型巨细胞动脉炎(LV-GCA)患者的临床和影像学特征。LV-GCA患者男性比例更高,更常出现颅部症状、发热≥38°C、风湿性多肌痛和高血压,诊断时ESR水平更高;TAK患者诊断延迟更长,更常出现大动脉脉搏消失、血管杂音、肢体跛行、心肌梗死/心绞痛及肾动脉狭窄所致高血压,且接受更高累积泼尼松剂量、更多传统免疫抑制剂和生物制剂,复发更频繁,随访期间更多新发血管狭窄/闭塞和血管增厚。作者认为两种疾病既有相似之处也有差异,是否属于同一疾病谱尚不明确。

要点

  • LV-GCA患者男性比例更高,更常出现颅部症状、发热≥38°C、风湿性多肌痛和高血压。
  • TAK患者诊断延迟更长,更常出现脉搏消失、血管杂音、肢体跛行和肾动脉狭窄所致高血压。
  • TAK患者累积泼尼松剂量更高、免疫抑制剂使用更多、复发更频繁,随访中新发血管狭窄/闭塞更多。

核心结论

  • TAK与LV-GCA患者既有相似之处也有差异,是否属于同一疾病谱尚不明确。
  • 随着对发病机制和病因的认识增加,这些问题的答案有望在未来明确。

研究设计与样本

  • 回顾性单中心研究,比较1996至2016年间诊断的59例TAK患者与127例LV-GCA患者的特征和结局。
  • 92%的患者在Reggio Emilia医院随访至少24个月,并复习了比较LV-GCA与TAK的已发表文献。

主要发现

  • LV-GCA患者男性比例更高(p=0.003),更常出现颅部症状(p=0.001)、发热≥38°C(p=0.007)、风湿性多肌痛(p=0.001)和高血压(p=0.001),诊断时ESR水平更高(p=0.0001)。
  • TAK患者从症状开始到诊断的延迟更长(p=0.048),更常出现大动脉脉搏消失(p=0.0001)、血管杂音(p=0.001)、肢体跛行(p=0.003)、心肌梗死/心绞痛(p=0.03)和肾动脉狭窄所致高血压(p=0.001)。
  • TAK患者接受更高的总累积泼尼松剂量(p=0.0001)和1年累积泼尼松剂量(p=0.001),泼尼松治疗时间更长(p=0.008),随访期间更常使用传统免疫抑制剂(p=0.0001)和生物制剂(p=0.0001)。
  • TAK患者复发更频繁(p=0.001),长期缓解无差异,随访期间新发血管手术更多(p=0.0001)。
  • 诊断时影像学:TAK患者更常出现血管狭窄/闭塞(p=0.0001),每人结构损伤血管数更多(p=0.0001);LV-GCA患者每人炎症血管数更多(p=0.0001)。

关键数值与推荐

  • 诊断时血管炎症和/或动脉损伤累及区域:LV-GCA患者胸主动脉(p=0.024)、腹主动脉(p=0.007)、腋动脉(p=0.018)、髂动脉(p=0.002)和股动脉(p=0.0001)受累更频繁。
  • TAK患者头臂干(p=0.011)、腹腔干(p=0.019)、肠系膜动脉(p=0.019)和肾动脉(p=0.005)受累更频繁。
  • 诊断时影像学动脉损伤:TAK患者更常累及颈总动脉(p=0.0001)、头臂干(p=0.006)、锁骨下动脉(p=0.0001)和降主动脉(p=0.022)。
  • 随访影像学:TAK患者更常出现新发血管狭窄/闭塞(p=0.0001)和新发血管增厚(p=0.002),新发扩张/动脉瘤无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare clinical and imaging characteristics in patients with Takayasu arteritis (TAK) and large vessel-giant cell arteritis (LV-GCA) in an Italian population. METHODS: We conducted a retrospective monocenter study comparing characteristics and outcomes of a cohort of 59 patients with TAK and a cohort of 127 patients with LV-GCA diagnosed between 1996 and 2016. Most of them (92%) were followed up for at least 24 months at Reggio Emilia Hospital (Italy). We also reviewed the literature discussing the results of the published manuscripts comparing LV-GCA to TAK RESULTS: LV-GCA patients had a higher prevalence of males (p = 0.003), and more frequently presented with cranial symptoms (p = 0.001), fever ≥38 °C (p = 0.007), polymyalgia rheumatica (p = 0.001), and hypertension (p = 0.001), and they had higher ESR levels at diagnosis (p = 0.0001). Differently, TAK patients had longer delay to diagnosis from the beginning of symptoms (p = 0.048), they presented more frequently with loss of pulses of large arteries (p = 0.0001), vascular bruits (p = 0.001), limb claudication (p = 0.003), myocardial infarction/angina (p = 0.03), and hypertension induced by renal artery stenosis (p = 0.001). Regarding treatment, TAK patients received a higher total and at 1 year cumulative prednisone doses (p = 0.0001 and p = 0.001, respectively), they had a longer duration of prednisone therapy (p = 0.008), and received during follow-up more frequently traditional immunosuppressants (p = 0.0001) and biological agents (p = 0.0001). Flares were more frequently observed in TAK patient (p = 0.001), while no differences were observed for long-term remission. New vascular procedures during the follow-up were more frequently performed in TAK patients (p = 0.0001). Regarding imaging at diagnosis, TAK patients had more frequently vascular stenosis/occlusion (p = 0.0001) and a higher number of vessels with structural damage per person (p = 0.0001), while LV-GCA patients had a higher number of inflamed vessels per person (p = 0.0001). Comparing the involved vascular districts at diagnosis for the presence of vessel inflammation and/or arterial damage, patients with LV-GCA had a more frequent involvement of thoracic and abdominal aorta (p = 0.024 and p = 0.007, respectively), and axillary, iliac and femoral arteries (p = 0.018, p = 0.002, and p = 0.0001. respectively), while in TAK patients, brachiocephalic, celiac, mesenteric and renal arteries were more frequently involved (p = 0.011, p = 0.019, p = 0.019, and p = 0.005, respectively). At imaging arterial damage at diagnosis was more frequently observed in TAK patients, specifically at common carotid, brachiocephalic, and subclavian arteries (p = 0.0001, p = 0.006, p = 0.0001, respectively) and descending aorta (p = 0.022). Regarding imaging during the follow-up, TAK patients developed more frequently new vascular stenosis/occlusion (p = 0.0001) and new vascular thickening (p = 0.002), no differences were observed for the development of new dilatation/aneurysm between the two vasculitides. CONCLUSION: Patients with TAK and LV-GCA show a number of similarities and also differences. Indeed, it is unclear whether they are part of the same disease spectrum or they are different conditions. As more information regarding the pathogenesis and etiology becomes known, answers to these questions are like to be forthcoming.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Boiardi L, Galli E, Macchioni P, et al. Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases. Semin Arthritis Rheum. 2023. PMID: 36780709. doi:10.1016/j.semarthrit.2023.152173

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。